PHK
IGMS

Point72 Hong Kong’s IGM Biosciences IGMS Stock Holding History

Point72 Hong Kong’s Portfolio IGMS Stock Details IGMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-238
Closed -$5K – 831
2022
Q3 		$5K Buy
+238
New +$4.81K ﹤0.01% 1786
2022
Q1 		– Sell
-1,149
Closed -$34K – 2068
2021
Q4 		$34K Buy
+1,149
New +$57.1K ﹤0.01% 1435
2021
Q1 		– Sell
-27
Closed -$2K – 1989
2020
Q4 		$2K Sell
27
-60
-69% -$4.22K ﹤0.01% 1644
2020
Q3 		$6K Buy
+87
New +$5.15K ﹤0.01% 1045
2019
Q4 		– Sell
-6,910
Closed -$123K – 1284
2019
Q3 		$123K Buy
+6,910
New +$139K 0.04% 413

Other funds holding IGMS

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Point72 Hong Kong's IGMS Position: Q4 2022 in Review

Point72 Hong Kong sold out of IGM Biosciences (IGMS) in Q4 2022, closing a stake of 238 shares — an estimated $5K sold.

Point72 Hong Kong first reported a position in IGMS in Q3 2019 and held it in 5 quarters. The position peaked at $123K in Q3 2019. 82 funds tracked by Wall St. Rank hold IGMS as of Q4 2022.

  • Point72 Hong Kong reported no remaining IGM Biosciences position as of Q4 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 238 IGM Biosciences shares in Q4 2022, an estimated $5K.
  • Point72 Hong Kong first reported a position in IGM Biosciences in Q3 2019 and held it in 5 quarters.
  • Point72 Hong Kong's IGM Biosciences position peaked at $123K in Q3 2019.
  • 82 funds tracked by Wall St. Rank held IGM Biosciences as of Q4 2022.

Based on Point72 Hong Kong's 13F filing for Q4 2022, filed 14 Feb 2023.